Erik Elfström is appointed new CFO for ChromoGenics as of September 1, 2022.

The annual general meeting of shareholders of ChromoGenics AB was held today on 19 May 2022. The annual general meeting…

ChromoGenics increased its net sales and completed a rights issue for SEK 54.4 million to accelerate growth

ChromoGenics’ Annual Report for 2021 in Swedish is now available in pdf-format on the company’s website, ChromoGenics. The Annual Report…

The Board of Directors of ChromoGenics AB (“ChromoGenics” or “the Company”) today announces the outcome of the new share issue…

ChromoGenics AB (“ChromoGenics” or “the Company”) today publishes a prospectus which has been approved and registered with the Swedish Financial…

The Board of Directors of ChromoGenics AB (“the Company”) announces today that the new issue of shares with preferential rights…

ChromoGenics increases its net sales and completes share issue for SEK 68.2 million, guaranteed to 80 percent, for accelerated growth.

The Board of Directors of ChromoGenics AB (”ChromoGenics” or ”the Company”) has today, with support pursuant to the authorization granted…

After solving the CFO role on a consulting basis in recent years, ChromoGenics is now starting the recruitment of a…

ChromoGenics is restructuring and strengthening its management team to accelerate the transformation to a profitable industrial company. 

ChromoGenics is now starting production of dynamic glass after a production stoppage of just under three weeks. Production is now…